05 May 2026
This webinar adresses
1. Recent declines in fentanyl-related overdose deaths
Recent declines in fentanyl-related overdose deaths reflect multiple overlapping improvements—including wider naloxone access, better treatment availability, and shifts in drug supply—but the landscape remains highly dynamic, making ongoing awareness of emerging trends essential for providers treating patients with opioid use disorder.
2. Data-driven insights that help clinicians adapt to evolving trends
Providers benefit from tools that help them understand patterns in their own patient populations, such as unexpected results, emerging trends, and positivity shifts, allowing for more informed testing decisions and patient discussions. Insight Analytics is Labcorp’s data analytics platform designed to support these needs.
3. Labcorp’s clinical drug testing solutions
Labcorp provides a range of tests that help clinicians monitor medications, support treatment for substance use disorders, and identify unexpected findings. With flexible testing options and clear result reporting, clinicians can choose the testing approach that best fits each patient’s needs.
Speaker
Richard Lundberg, PhD
Dr. Richard Lundberg completed a PhD in pharmacology from the University of Minnesota Medical School and has been employed in forensic, pharmaceutical and clinical drug testing for 23 years. He has been with Labcorp for 19 years and serves as the Director of Clinical Certifying overseeing the data review of medical drug monitoring, medication-assisted treatment, and therapeutic drug monitoring testing programs.